p. 1-8
Anticancer agent xanthohumol inhibits IL-2 induced signaling pathways involved in T cell proliferation
Yongbo Liu, Xiaohua Gao, Dorrah Deeb, Ali S. Arbab, Scott A. Dulchavsky and Subhash C. Gautam
Abstract
Full Text (IP)
p. 9-18
Nox4 inhibition enhances the cytotoxicity of cisplatin in human renal cancer cells
Guimin Chang, Li Chen, Hui-Min Lin, Yan Lin and Jodi K. Maranchie
Abstract
Full Text (IP)
p. 19-29
Are fragile sites “Hot-Spots”:
A causative factor in tumor biology
Ajit Kumar Saxena
Abstract
Full Text (IP)
p. 31-37
Intra-arterial bevacizumab with blood brain barrier disruption in a glioblastoma xenograft model
Jan-Karl Burkhardt, Alejandro Santillan, Christoph P. Hofstetter, Paul Christos, Nick Berry, Benjamin J. Shin, Conor P. Foley, Demirkan B. Gürsel, Douglas J. Ballon, Y. Pierre Gobin and John A. Boockvar
Abstract
Full Text (IP)
p. 39-49
D-Pinitol attenuates 7, 12 dimethylbenz [a] anthracene induced hazards through modulating protein bound carbohydrates, adenosine triphosphatases and lysosomal enzymes during experimental mammary carcinogenesis
Thamaraiselvan Rengarajan, Natarajan Nandakumar and Maruthaiveeran Periyasamy Balasubramanian
Abstract
Full Text (IP)
p. 51-64
Inhibition of cell proliferation and induction of apoptosis by CDDO-Me in pancreatic cancer cells is ROS-dependent
Dorrah Deeb, Xiaohua Gao, Yong Bo Liu and Subhash C. Gautam
Abstract
Full Text (IP)
p. 65-69
Nedaplatin and irinotecan for patients with recurrent small cell lung cancer
Miki Ohe, Fumihiro Oshita, Yoshiyuki Kenmotsu, Makiko Sugiura, Shuji Murakami, Tetsuro Kondo, Haruhiro Saito and Kouzo Yamada
Abstract
Full Text (IP)
p. 71-81
Phase I/II study of oral erlotinib for treatment of relapsed/refractory glioblastoma multiforme and anaplastic astrocytoma
Kartik Kesavabhotla, Cody D. Schlaff, Benjamin Shin, Lynn Mubita, Rachel Kaplan, Apostolos J. Tsiouris, Susan C. Pannullo, Paul Christos, Ehud Lavi, Ronald Scheff and John A. Boockvar
Abstract
Full Text (IP)